Luna Han

Ms. Luna Han


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2026 in Current Oncology
Verified
Journal Article
Open access
PDF file
LHLuna Han
Luna Han
TJTeresia John
Teresia John
MHMohid Hassan
Mohid Hassan
Jonathan J. WiscoJonathan J. Wisco
Jonathan J. Wisco
Purpose: To investigate whether quantitative nuclear morphology from routine H&E images can be used as a biomarker for glioblastoma (GBM) biology and prognosis. Methods: Nuclear eccentricity, circularity, density, and heterogeneity were measured from H&E whole-slide images in the TCGA-GBM cohort and independently validated in the CPTAC-GBM cohort. A multivariable Cox model was used to test the survival associations in both cohorts, and transcriptome-wide and gene set enrichment analyses were conducted in TCGA RNA data and validated using CPTAC RNA and proteomic data. Results: In TCGA-GBM, greater nuclear eccentricity was associated with better survival (HR, 0.85; 95% CI, 0.71–1.02; p = 0.089), with the same favorable association independently observed in CPTAC-GBM (HR, 0.74; 95% CI, 0.60–0.90; p = 0.003). No individual gene association with eccentricity was statistically significant in the TCGA cohort, but pathway analysis identified its association with epithelial–mesenchymal transition (EMT), inflammatory, hypoxic, and stress-related programs. Across the TCGA RNA, CPTAC RNA and proteomic datasets, greater eccentricity was consistently associated with increased NF-κB signaling, collagen biosynthesis, and ER-to-Golgi transport and decreased L1CAM-related and neuronal-projection programs, with EMT showing the strongest cross-cohort consistency. Conclusions: Nuclear eccentricity from patient H&E slide images is a potential biomarker associated with survival and transcriptional/translational programs in GBM. Integrating quantitative pathology with RNA and proteomic data may provide an accessible approach for GBM prognosis and tumor biology characterization.

1 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
LHLuna Han
Luna Han
TJTeresia John
Teresia John
MHMohid Hassan
Mohid Hassan
Jonathan J. WiscoJonathan J. Wisco
Jonathan J. Wisco
Purpose: To investigate whether quantitative nuclear morphology from routine H&E images can be used as a biomarker for glioblastoma (GBM) biology and prognosis. Methods: Nuclear eccentricity, circularity, density, and heterogeneity were measured from H&E whole-slide images in the TCGA-GBM cohort and independently validated in the CPTAC-GBM cohort. A multivariable Cox model was used to test the survival associations in both cohorts, and transcriptome-wide and gene set enrichment analyses were conducted in TCGA and validated using CPTAC RNA and proteomic data. Results: In TCGA-GBM, greater nuclear eccentricity was associated with better survival (HR 0.85; 95% CI, 0.71–1.02; P=0.089), with the same favorable association independently observed in CPTAC-GBM (HR, 0.74; 95% CI, 0.60–0.90; P=0.003). No individual gene association with eccentricity was statistically significant in the TCGA cohort, but pathway analysis identified its association with epithelial-mesenchymal transition (EMT), inflammatory, hypoxic, and stress-related programs. Across TCGA RNA, CPTAC RNA, and proteomic dataset, greater eccentricity was consistently associated with increased NF-κB signaling, collagen biosynthesis, and ER-to-Golgi transport and decreased L1CAM-related and neuronal-projection programs, with EMT showing the strongest cross-cohort consistency. Conclusion: Nuclear eccentricity from patient H&E slide images is a potential biomarker associated with survival and transcriptional/translational programs in GBM. Integrating quantitative pathology with RNA and proteomic data may provide an accessible approach for GBM prognosis and tumor biology characterization.